Introduction Patent foramen ovale (PFO) closure is a widely performed procedure.
Understanding the anatomy is mandatory in order to perform the procedure successfully …

Aims Patients with cryptogenic embolic events and a patent foramen ovale (PFO) are at risk
of paradoxical embolism causing recurrent cerebral events; however, transcatheter PFO …

Background Polypropylene suture mediated patent foramen ovale (PFO) closure may
obviate the risk and limitations associated with umbrella-like closure devices such as …

Background Most current intracardiac closure devices target the atrial septal defect.
However, defects such as the patent foramen ovale (PFO) have unique structural features …

Cryptogenic stroke is the final diagnosis in almost 40% of ischemic acute cerebrovascular
events. There is currently no definitive clinical evidence that percutaneous closure of patent …

Percutaneous closure of patent foramen ovale (PFO) has been proposed as the treatment of
choice for young high-risk patients who suffered cryptogenic stroke and/or peripheral …

Background: Patent foramen ovale (PFO) is an interatrial communication whose
management is controversial. Several manufacturers have submitted protocols for Food and …

Recently, in the span of six months twelve meta-analyses have been published regarding
patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events …

Percutaneous patent foramen ovale (PFO) closure is an intervention aimed to prevent
cardioembolic stroke. It recently proved to be superior to antiplatelet therapy in preventing …

Background Percutaneous closure of atrial septal defect (ASD) and patent foramen ovale
(PFO) are increasingly being performed. Eff ective closure rate depends on the anatomy of …